{"id":233821,"date":"2026-01-27T11:08:00","date_gmt":"2026-01-27T09:08:00","guid":{"rendered":"https:\/\/militra.lt\/?p=233821"},"modified":"2026-07-21T16:03:01","modified_gmt":"2026-07-21T13:03:01","slug":"gimdos-kaklelio-vezio-prevencija-ka-svarbu-zinoti-kiekvienam","status":"publish","type":"post","link":"https:\/\/militra.lt\/en\/gimdos-kaklelio-vezio-prevencija-ka-svarbu-zinoti-kiekvienam\/","title":{"rendered":"Gimdos kaklelio v\u0117\u017eio prevencija: k\u0105 svarbu \u017einoti kiekvienam"},"content":{"rendered":"\n<h2 class=\"wp-block-heading\">Kod\u0117l svarbi gimdos kaklelio v\u0117\u017eio prevencija?<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Sausio paskutin\u0119 savait\u0119 minima&nbsp;<strong>Europos gimdos kaklelio v\u0117\u017eio prevencijos savait\u0117<\/strong>, kurios tikslas \u2013 atkreipti visuomen\u0117s d\u0117mes\u012f \u012f \u0161i\u0105 lig\u0105, jos rizikos veiksnius ir veiksmingas prevencijos priemones. Gimdos kaklelio v\u0117\u017eys da\u017eniausiai vystosi l\u0117tai, per 10\u201320 met\u0173, tod\u0117l laiku nustatyti pakitimai leid\u017eia i\u0161vengti sunkios ligos ir jos pasekmi\u0173.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Moksliniai tyrimai rodo, kad gimdos kaklelio v\u0117\u017eys da\u017eniausiai i\u0161sivysto veikiant&nbsp;<strong>keliems rizikos veiksniams vienu metu<\/strong>, o vienas svarbiausi\u0173 j\u0173 \u2013&nbsp;<strong>\u017emogaus papilomos viruso (\u017dPV) infekcija<\/strong>.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Pagrindiniai rizikos veiksniai<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Did\u017eiausi\u0105 reik\u0161m\u0119 gimdos kaklelio v\u0117\u017eio i\u0161sivystymui turi&nbsp;<strong>\u017dPV infekcija gimdos kaklelyje<\/strong>. Be to, rizika did\u0117ja, jei:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>da\u017enai kei\u010diasi lytiniai partneriai;<\/li>\n\n\n\n<li>lytiniai santykiai pradedami jauname am\u017eiuje (iki 18 met\u0173);<\/li>\n\n\n\n<li>ilg\u0105 laik\u0105 vartojami geriamieji kontraceptikai;<\/li>\n\n\n\n<li>r\u016bkoma ar veikia kiti nepalank\u016bs aplinkos veiksniai;<\/li>\n\n\n\n<li>svarb\u0173 vaidmen\u012f turi ir moters hormonin\u0117 b\u016bkl\u0117.<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Prad\u017eioje gimdos kaklelio l\u0105stel\u0117s tampa pakitusios, ta\u010diau dar n\u0117ra v\u0117\u017ein\u0117s. \u0160ie&nbsp;<strong>ikiv\u0117\u017einiai poky\u010diai<\/strong>&nbsp;da\u017enai nesukelia joki\u0173 simptom\u0173, ta\u010diau laiku juos nusta\u010dius galima s\u0117kmingai gydyti.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Kaip galima u\u017ekirsti keli\u0105 ligai?<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">P\u0160iuo metu&nbsp;<strong>efektyviausias gimdos kaklelio v\u0117\u017eio prevencijos b\u016bdas<\/strong>&nbsp;\u2013 reguliar\u016bs patikrinimai ir ikiv\u0117\u017eini\u0173 pakitim\u0173 gydymas.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Lietuvoje nuo 2004 m. vykdoma <strong>valstyb\u0117s finansuojama gimdos kaklelio v\u0117\u017eio prevencijos programa<\/strong>. Pagal j\u0105 moterys nuo <strong>25 iki 60 met\u0173<\/strong> kas <strong>3 metus<\/strong> gali <strong>nemokamai atlikti PAP test\u0105<\/strong>, kuris leid\u017eia aptikti ikiv\u0117\u017einius poky\u010dius dar prie\u0161 i\u0161sivystant v\u0117\u017eiui.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">\u017dPV infekcija ir vakcinacija<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">\u017dmogaus papilomos virusas yra&nbsp;<strong>da\u017eniausia pasaulyje lyti\u0161kai plintanti infekcija<\/strong>. \u017dinoma daugiau nei 200 \u017dPV tip\u0173, i\u0161 kuri\u0173 apie 40 aptinkami lytini\u0173 organ\u0173 gleivin\u0117je. Kai kurie j\u0173 pasi\u017eymi didele onkogenine rizika ir gali sukelti:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>gimdos kaklelio v\u0117\u017e\u012f,<\/li>\n\n\n\n<li>i\u0161ang\u0117s ir lytini\u0173 organ\u0173 v\u0117\u017e\u012f,<\/li>\n\n\n\n<li>tam tikrus galvos ir kaklo v\u0117\u017einius susirgimus (tiek vyrams, tiek moterims).<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Nuo 2016 m. Lietuvoje \u017dPV vakcina nemokamai skiepijamos 11 met\u0173 mergait\u0117s, o <strong>nuo 2023 m. \u2013 <\/strong>ir berniukai.<strong> <\/strong>Vakcinacij\u0105 sudaro <strong>dvi doz\u0117s<\/strong>, tarp kuri\u0173 turi b\u016bti ne trumpesnis nei 6 m\u0117nesi\u0173 intervalas. Skiepai gali pad\u0117ti i\u0161vengti <strong>iki 75 % gimdos kaklelio v\u0117\u017eio atvej\u0173<\/strong>.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Svarbu \u017einoti, kad vakcina yra&nbsp;<strong>profilaktin\u0117<\/strong>&nbsp;\u2013 ji ne gydo jau esamus pakitimus, bet apsaugo nuo \u017dPV tip\u0173, kuriais dar nebuvo u\u017esikr\u0117sta.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Kod\u0117l svarbu tikrintis reguliariai?<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Apie&nbsp;<strong>90 % \u017dPV infekcij\u0173<\/strong>&nbsp;per kelerius metus i\u0161nyksta savaime, ta\u010diau likusiais atvejais virusas gali sukelti l\u0117tin\u012f u\u017edegim\u0105 ir ilgainiui \u2013 v\u0117\u017einius pakitimus. Reguliar\u016bs patikrinimai leid\u017eia:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>laiku aptikti ikiv\u0117\u017einius poky\u010dius,<\/li>\n\n\n\n<li>u\u017ekirsti keli\u0105 invaziniam v\u0117\u017eiui,<\/li>\n\n\n\n<li>padidinti s\u0117kmingo gydymo galimybes.<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\">Pabaigai<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Sveikatos ra\u0161tingumas, prevencija ir pirmieji veiksmai pasteb\u0117jus rizikos veiksnius yra svarbi visuomen\u0117s saugumo dalis. Daugiau apie lig\u0173 prevencij\u0105, sveikatos rizikas ir pirmosios pagalbos principus galima su\u017einoti <strong>edukaciniuose mokymuose<\/strong>, kurie padeda stiprinti s\u0105moningum\u0105 ir atsaking\u0105 po\u017ei\u016br\u012f \u012f sveikat\u0105.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">\ud83d\udc49Daugiau apie pirm\u0105j\u0105 pagalb\u0105 galima su\u017einoti  <a href=\"https:\/\/militra.lt\/product\/pp006-pirmos-pagalbos-pazymejimas-imoniu-istaigu-ir-organizaciju-darbuotojams\/\" title=\"\"><strong>Militra.lt mokymuose<\/strong>.<\/a><\/p>\n\n\n\n<style>\n.militra-accordion {\n  max-width: 900px;\n  margin: 1.5rem auto;\n  font-family: inherit;\n}\n\n.militra-accordion details {\n  border-radius: 8px;\n  margin-bottom: 12px;\n  overflow: hidden;\n  border: 1px solid #f0c9a5;\n}\n\n.militra-accordion summary {\n  background-color: #f58220;\n  color: #ffffff;\n  padding: 16px 20px;\n  font-weight: 600;\n  cursor: pointer;\n  list-style: none;\n  position: relative;\n}\n\n.militra-accordion summary::-webkit-details-marker {\n  display: none;\n}\n\n.militra-accordion summary::after {\n  content: \"+\";\n  position: absolute;\n  right: 20px;\n  font-size: 20px;\n  font-weight: 700;\n}\n\n.militra-accordion details[open] summary::after {\n  content: \"\u2013\";\n}\n\n.militra-accordion .content {\n  background-color: #f5f5f5;\n  padding: 16px 20px;\n  color: #333;\n  line-height: 1.6;\n}\n<\/style>\n\n<div class=\"militra-accordion\">\n\n  <details>\n    <summary>Kod\u0117l svarb\u016bs ankstyvi patikrinimai?<\/summary>\n    <div class=\"content\">\n      Gimdos kaklelio v\u0117\u017eys da\u017eniausiai vystosi l\u0117tai, tod\u0117l ankstyvi patikrinimai leid\u017eia laiku nustatyti pakitimus ir u\u017ekirsti keli\u0105 ligos progresavimui.\n    <\/div>\n  <\/details>\n\n  <details>\n    <summary>Pagrindinis rizikos veiksnys<\/summary>\n    <div class=\"content\">\n      \u017dmogaus papilomos viruso (\u017dPV) infekcija yra pagrindinis gimdos kaklelio v\u0117\u017eio rizikos veiksnys.\n    <\/div>\n  <\/details>\n\n  <details>\n    <summary>K\u0105 leid\u017eia nustatyti PAP testas?<\/summary>\n    <div class=\"content\">\n      Reguliarus PAP testas padeda aptikti ikiv\u0117\u017einius gimdos kaklelio pakitimus dar prie\u0161 jiems tampant pavojingais.\n    <\/div>\n  <\/details>\n\n  <details>\n    <summary>Kod\u0117l svarbi \u017dPV vakcina?<\/summary>\n    <div class=\"content\">\n      \u017dPV vakcina apsaugo tiek mergaites, tiek berniukus nuo virus\u0173 tip\u0173, galin\u010di\u0173 sukelti v\u0117\u017einius susirgimus.\n    <\/div>\n  <\/details>\n\n  <details>\n    <summary>K\u0105 rei\u0161kia prevencija?<\/summary>\n    <div class=\"content\">\n      Prevencija ir \u017einios yra veiksmingiausia investicija \u012f ilgalaik\u0119 sveikat\u0105 ir gyvenimo kokyb\u0119.\n    <\/div>\n  <\/details>\n\n<\/div>\n\n\n\n\n<p class=\"wp-block-paragraph\"><\/p>\n\n{&#8222;@context&#8221;: &#8222;https:\/\/schema.org&#8221;, &#8222;@type&#8221;: &#8222;FAQPage&#8221;, &#8222;mainEntity&#8221;: [{&#8222;@type&#8221;: &#8222;Question&#8221;, &#8222;name&#8221;: &#8222;Kod\u0117l svarb\u016bs ankstyvi patikrinimai?&#8221;, &#8222;acceptedAnswer&#8221;: {&#8222;@type&#8221;: &#8222;Answer&#8221;, &#8222;text&#8221;: &#8222;Gimdos kaklelio v\u0117\u017eys da\u017eniausiai vystosi l\u0117tai, tod\u0117l ankstyvi patikrinimai leid\u017eia laiku nustatyti pakitimus ir u\u017ekirsti keli\u0105 ligos progresavimui.&#8221;}}, {&#8222;@type&#8221;: &#8222;Question&#8221;, &#8222;name&#8221;: &#8222;Pagrindinis rizikos veiksnys&#8221;, &#8222;acceptedAnswer&#8221;: {&#8222;@type&#8221;: &#8222;Answer&#8221;, &#8222;text&#8221;: &#8222;\u017dmogaus papilomos viruso (\u017dPV) infekcija yra pagrindinis gimdos kaklelio v\u0117\u017eio rizikos veiksnys.&#8221;}}, {&#8222;@type&#8221;: &#8222;Question&#8221;, &#8222;name&#8221;: &#8222;K\u0105 leid\u017eia nustatyti PAP testas?&#8221;, &#8222;acceptedAnswer&#8221;: {&#8222;@type&#8221;: &#8222;Answer&#8221;, &#8222;text&#8221;: &#8222;Reguliarus PAP testas padeda aptikti ikiv\u0117\u017einius gimdos kaklelio pakitimus dar prie\u0161 jiems tampant pavojingais.&#8221;}}, {&#8222;@type&#8221;: &#8222;Question&#8221;, &#8222;name&#8221;: &#8222;Kod\u0117l svarbi \u017dPV vakcina?&#8221;, &#8222;acceptedAnswer&#8221;: {&#8222;@type&#8221;: &#8222;Answer&#8221;, &#8222;text&#8221;: &#8222;\u017dPV vakcina apsaugo tiek mergaites, tiek berniukus nuo virus\u0173 tip\u0173, galin\u010di\u0173 sukelti v\u0117\u017einius susirgimus.&#8221;}}, {&#8222;@type&#8221;: &#8222;Question&#8221;, &#8222;name&#8221;: &#8222;K\u0105 rei\u0161kia prevencija?&#8221;, &#8222;acceptedAnswer&#8221;: {&#8222;@type&#8221;: &#8222;Answer&#8221;, &#8222;text&#8221;: &#8222;Prevencija ir \u017einios yra veiksmingiausia investicija \u012f ilgalaik\u0119 sveikat\u0105 ir gyvenimo kokyb\u0119.&#8221;}}]}","protected":false},"excerpt":{"rendered":"<p>Kod\u0117l svarbi gimdos kaklelio v\u0117\u017eio prevencija? Sausio paskutin\u0119 savait\u0119 minima&nbsp;Europos gimdos kaklelio v\u0117\u017eio prevencijos savait\u0117, kurios tikslas \u2013 atkreipti visuomen\u0117s d\u0117mes\u012f \u012f \u0161i\u0105 lig\u0105, jos rizikos veiksnius ir veiksmingas prevencijos priemones. Gimdos kaklelio v\u0117\u017eys da\u017eniausiai vystosi l\u0117tai, per 10\u201320 met\u0173, tod\u0117l laiku nustatyti pakitimai leid\u017eia i\u0161vengti sunkios ligos ir jos pasekmi\u0173. Moksliniai tyrimai rodo, kad [&hellip;]<\/p>\n","protected":false},"author":8205,"featured_media":233829,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"slim_seo":{"title":"Gimdos kaklelio v\u0117\u017eio prevencija: \u017dPV, patikros ir skiepai","description":"Su\u017einokite apie gimdos kaklelio v\u0117\u017eio rizikos veiksnius, \u017dPV infekcij\u0105, prevencijos programas ir skiepus. Reguliar\u016bs patikrinimai gali i\u0161gelb\u0117ti gyvyb\u0119."},"_glsr_average":0,"_glsr_ranking":0,"_glsr_reviews":0,"_slim_seo_primary_term_category":0,"_slim_seo_primary_term_post_tag":0,"footnotes":""},"categories":[45],"tags":[612,605,613,125,610,611,615,614],"class_list":["post-233821","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-naujienos","tag-gimdos-kaklelio-vezys","tag-luziai","tag-pap-testas","tag-pirmoji-pagalba","tag-skiepai-nuo-zpv","tag-vezio-prevencija","tag-zmogaus-papilomos-virusas","tag-zpv"],"blocksy_meta":{"styles_descriptor":{"styles":{"desktop":"","tablet":"","mobile":""},"google_fonts":[],"version":8}},"acf":[],"_links":{"self":[{"href":"https:\/\/militra.lt\/en\/wp-json\/wp\/v2\/posts\/233821","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/militra.lt\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/militra.lt\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/militra.lt\/en\/wp-json\/wp\/v2\/users\/8205"}],"replies":[{"embeddable":true,"href":"https:\/\/militra.lt\/en\/wp-json\/wp\/v2\/comments?post=233821"}],"version-history":[{"count":5,"href":"https:\/\/militra.lt\/en\/wp-json\/wp\/v2\/posts\/233821\/revisions"}],"predecessor-version":[{"id":271862,"href":"https:\/\/militra.lt\/en\/wp-json\/wp\/v2\/posts\/233821\/revisions\/271862"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/militra.lt\/en\/wp-json\/wp\/v2\/media\/233829"}],"wp:attachment":[{"href":"https:\/\/militra.lt\/en\/wp-json\/wp\/v2\/media?parent=233821"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/militra.lt\/en\/wp-json\/wp\/v2\/categories?post=233821"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/militra.lt\/en\/wp-json\/wp\/v2\/tags?post=233821"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}